Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma

We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new vessel (CNV) formation overlying choroidal osteoma over a mean follow-up of 26 months. Mean number of injections was 2.4 at 6 months, 3.2 at 1...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Mansour, Ahmad M., Arevalo, J. Fernando, Al Kahtani, Eman, Zegarra, Hernando, Abboud, Emad, Anand, Rajiv, Ahmadieh, Hamid, Sisk, Robert A., Mirza, Salman, Tuncer, Samuray, Navea Tejerina, Amparo, Mataix, Jorge, Ascaso, Francisco J., Pulido, Jose S., Guthoff, Rainer, Goebel, Winfried, Roh, Young Jung, Banker, Alay S., Gentile, Ronald C., Martinez, Isabel Alonso, Morris, Rodney, Panday, Neeraj, Min, Park Jung, Mercé, Emilie, Lai, Timothy Y. Y., Massoud, Vicky, Ghazi, Nicola G.
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi Publishing Corporation 2014
נושאים:
Clinical Study
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4132478/
https://ncbi.nlm.nih.gov/pubmed/25147732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/210458
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים